Differential effects of protein kinase C-eta on apoptosis versus senescence

Keyphrases

• Apoptosis 100%
• Protein Kinase 100%
• Senescence 100%
• Differential Effects 100%
• Knockdown 45%
• Myeloid Cell leukemia-1 (Mcl-1) 36%
• Doxorubicin 27%
• Cell Survival 9%
• Induced Apoptosis 9%
• Breast Cancer Cells 9%
• Small Interfering RNA (siRNA) 9%
• MCF-7 Cells 9%
• Breast Cancer 9%
• Cellular Sensitivity 9%
• MCF-7 9%
• Anti-apoptotic 9%
• Anti-apoptotic Proteins 9%
• Proliferative Activity 9%
• Chemoresistance 9%
• Paclitaxel 9%
• Proteasomal Degradation 9%
• β-Galactosidase (β-Gal) 9%
• Senescence-associated 9%
• T47D Breast Cancer Cells 9%
• T47D Cells 9%
• Cell Cycle Inhibitors 9%
• Clonogenic Survival 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Protein Kinase C Eta 100%
• Breast Cancer 27%
• Doxorubicin 27%
• Antiapoptotic 18%
• Phosphotransferase 9%
• Small Interfering RNA 9%
• Malignant Neoplasm 9%
• Antiinfective Agent 9%
• Paclitaxel 9%
• Drug Resistance 9%
• Galactosidase 9%
• Protein Mcl 1 9%

Biochemistry, Genetics and Molecular Biology

• Protein Kinase C 100%
• Doxorubicin 27%
• Cancer Cell 18%
• Kinase 9%
• Small Interfering RNA 9%
• Phosphotransferase 9%
• Cell Survival 9%
• Cell Cycle 9%
• Drug Resistance 9%
• Galactosidase 9%